Parle Global Technologies, India, in JV with Freund Corporation, Japan
The aim of the JV is to initially launch the series of dry granulation systems with unique design and construction philosophy
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
DuPont Nutrition & Health helps to reduce health risks for overweight consumers
New findings from clinical study show link between metabolic health benefits of HOWARU shape and gut microbiome
Strides Vivimed JV receives approval for Albendazole tabs
The product, used to treat certain infections caused by tapeworm, will be launched immediately
Delivering a baby increases, then lowers, risk of breast cancer: Study
Researchers found that the breast cancer risk peaks 4.6 years after a woman’s most recent birth but then begins to fall
Cadila Healthcare arm gets USFDA nod for ulcer treatment injection
Cadila Healthcare said the product will be manufactured at Liva Pharma's manufacturing facility at Vadodara
Mundipharma to distribute Norspan in Japan
Norspan is indicated for the relief of chronic pain associated with osteoarthritis and lower back pain
Lupin receives tentative US FDA approval for Apixaban tabs
The drug is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, prophylaxis of…
Roche’s lung cancer combo treatment wins FDA approval
The approval was based on results from a late-stage study, which showed the Tecentriq regimen helped patients with metastatic…
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study
The study, known as 'EAGLE', did not improve overall survival compared with standard chemotherapy in patients with the…
Lupin’s Pithampur Unit-3 receives EIR from US FDA
The facility manufactures dermatological products, dry product inhalers and metered dose inhalers
Amlodipine/Valsartan recalled for possible cancer risk
An impurity detected above specification limits in an active ingredient manufactured by Mylan India
Alembic Pharmaceuticals gets US FDA nod for ophthalmic solution
The approved product is therapeutically equivalent to the reference listed drug product Patanol ophthalmic solution, 0.1 per cent,…
AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug
The company will promote and distribute Dapagliflozin under the brand name GLEDEPA
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody
Eisai and UCL will conduct joint research in Alzheimer's disease for novel anti-tau antibody E2814
Polish Investment & Trade Agency to be part of CPhI & P-MEC India 2018
Polish companies can offer a competitive price while maintaining high quality standards of medicines
Datwyler starts commercial production at First Line in Pune, India
Datwyler has been focusing on high-end rubber formulations for products like lyo and serum vials
US FDA completes inspection of Lupin’s Mandideep location
As a company, Lupin has committed to an enhanced Quality Management System and Compliance Sustainability Plan
LOC of 70th IPC organises review meeting at FICCI House
Organisers of 70thIPC will be organising a breakfast meet of top 50 pharma CEOs with Venkaiah Naidu, Vice President of India
New potential breast cancer drug identified
The new compound is a potential highly effective, next-line treatment
Third edition of India Pharma Week gears up for grand debut in Delhi-NCR
Originally incepted in 2006, the CPhI & P-MEC India exhibition has grown remarkably larger over the years